Alerts will be sent to your verified email
Verify Email
ZENITHDRUG
|
Zenith Drugs
|
Bharat Immunological
|
Curis Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.81 % | 0.0 | 76.73 % |
|
5yr average Equity Multiplier
|
3.92 | 3.08 | 1.91 |
|
5yr Average Asset Turnover Ratio
|
1.08 | 0.61 | 1.07 |
|
5yr Avg Net Profit Margin
|
5.08 % | -18.38 % | 8.37 % |
|
Price to Book
|
0.0 | 0.97 | 0.0 |
|
P/E
|
20.12 | 0.0 | 11.92 |
|
5yr Avg Cash Conversion Cycle
|
-5.9 Days | 206.63 Days | 45.79 Days |
|
Inventory Days
|
59.46 Days | 125.06 Days | 77.61 Days |
|
Days Receivable
|
153.74 Days | 61.4 Days | 65.45 Days |
|
Days Payable
|
283.33 Days | 117.81 Days | 245.93 Days |
|
5yr Average Interest Coverage Ratio
|
3.87 | -2.32 | 5.43 |
|
5yr Avg ROCE
|
26.61 % | -44.64 % | 36.41 % |
|
5yr Avg Operating Profit Margin
|
9.63 % | -18.7 % | 16.92 % |
|
5 yr average Debt to Equity
|
1.03 | 0.71 | 0.12 |
|
5yr CAGR Net Profit
|
17.92 % | 23.51 % | 65.64 % |
|
5yr Average Return on Assets
|
5.28 % | -10.1 % | 9.21 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.98 % | 59.25 % | 68.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zenith Drugs
|
Bharat Immunological
|
Curis Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|